GSK PLC-SPON ADR (GSK)
US37733W2044 - ADR
ChartMill assigns a Buy % Consensus number of 74% to GSK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 47.22. This target is 16.34% above the current price.
GSK was analyzed by 32 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about GSK.
In the previous month the buy percentage consensus was at a similar level.
GSK was analyzed by 32 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-04 | Guggenheim | Upgrade | Neutral -> Buy |
| 2024-01-23 | Morgan Stanley | Initiate | Equal-Weight |
| 2024-01-03 | Jefferies | Upgrade | Hold -> Buy |
| 2022-02-11 | DZ Bank | Downgrade | Buy -> Hold |
| 2021-11-05 | Barclays | Upgrade | Underweight -> Equal-Weight |
| 2021-07-29 | Barclays | Reiterate | Underweight |
| 2021-07-08 | Berenberg Bank | Reiterate | Buy |
| 2021-07-07 | Liberum Capital | Reiterate | Reiteration |
| 2021-06-24 | Deutsche Bank | Upgrade | Hold |
| 2021-06-22 | Shore Capital | Reiterate | Hold |
| 2021-06-16 | Libertas Partners | Reiterate | Buy |
| 2021-06-14 | Berenberg Bank | Reiterate | Buy |
| 2021-06-11 | Deutsche Bank | Reiterate | Sell |
| 2021-05-19 | Deutsche Bank | Reiterate | Sell |
| 2021-05-10 | Berenberg Bank | Reiterate | Buy |
| 2021-04-21 | Shore Capital | Reiterate | Hold |
| 2021-04-16 | Berenberg Bank | Reiterate | Buy |
| 2021-04-15 | Liberum Capital | Reiterate | Buy |
| 2021-04-15 | Citigroup | Reiterate | Neutral |
| 2021-04-12 | JP Morgan Cazenove | Reiterate | Neutral |
| 2021-03-04 | Deutsche Bank | Reiterate | Sell |
| 2021-02-10 | Berenberg Bank | Reiterate | Buy |
| 2021-02-10 | Deutsche Bank | Reiterate | Sell |
| 2021-02-09 | JP Morgan Cazenove | Reiterate | Neutral |